The ubiquity of the tabletability flip phenomenon.

Bonding area Generality Mixture Plasticity Tabletability flip

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
25 Aug 2023
Historique:
received: 19 06 2023
revised: 07 07 2023
accepted: 19 07 2023
medline: 21 8 2023
pubmed: 27 7 2023
entrez: 26 7 2023
Statut: ppublish

Résumé

The plasticity of materials plays a critical role in adequate powder tabletability, which is required in developing a successful tablet product. Generally, a more plastic material can develop larger bonding areas when other factors are the same, leading to higher tabletability than less plastic materials. However, it was observed that, for a solid form of a compound with poorer tabletability, a mixture with microcrystalline cellulose (MCC) can actually exhibit better tabletability, a phenomenon termed tabletability flip. Hence, there is a chance that a solid form with poor tabletability could have been erroneously eliminated based on the expected tabletability challenges during tablet manufacturing. This study was conducted to investigate the generality of this phenomenon using two polymorph pairs, a salt and free acid pair, a crystalline and amorphous solid dispersion pair, and a pair of chemically distinct crystals. Results show that tabletability flip occurred in all six systems tested, including five pairs of binary mixtures with MCC and one pair in a realistic generic tablet formulation, suggesting the broad occurrence of the tabletability flip phenomenon, where both compaction pressure and the difference in plasticity between the pair of materials play important roles.

Identifiants

pubmed: 37495026
pii: S0378-5173(23)00682-8
doi: 10.1016/j.ijpharm.2023.123262
pii:
doi:

Substances chimiques

Tablets 0
Powders 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123262

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Zijian Wang (Z)

Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.

Chenguang Wang (C)

Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.

Deepak Bahl (D)

Bristol-Myers Squibb, 556 Morris Avenue, Summit, NJ 07901, USA.

Changquan Calvin Sun (CC)

Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: sunx0053@umn.edu.

Articles similaires

Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Nitriles Tensile Strength Materials Testing Gloves, Protective Product Packaging
Calcium Carbonate Sand Powders Construction Materials Materials Testing
Animals Rumen Methane Fermentation Cannabis

Classifications MeSH